Brief: Apontis Pharma Q1 EBITDA At EUR 2.4 Mln

Apontis Pharma AG

10/05/2022 06:34

May 10 (Reuters) - APONTIS PHARMA AG  APPHG.DE :
    * CONTINUES STRONG PROFITABLE GROWTH IN Q1 2022
    * Q1 EBITDA 2.4 MILLION EUR
    * Q1 EBITDA INCREASES BY 162% TO EUR 2.4 MILLION DESPITE
INVESTMENTS IN SINGLE PILL GROWTH
    * Q1 NET INCOME RISES REVENUE-DRIVEN TO EUR 1.6 MILLION (3M
2021:
EUR 0.3 MILLION)
    * Q1 TOTAL REVENUES GROW FASTER THAN PHARMA SECTOR BY 31% TO
EUR
14.3 MILLION
    * FOR 2022 FINANCIAL YEAR, EXECUTIVE BOARD CONFIRMS ITS
FORECAST

Source text for Eikon:  ID:nEQ41nB4Ba 
Further company coverage:  APPHG.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))